Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, reposted BHOC – Biological Hemoglobin Oxygen Carrier’s post on LinkedIn:
“𝗛𝗲𝗺𝗼𝗽𝘂𝗿𝗲: 𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗢𝘅𝘆𝗴𝗲𝗻 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗶𝗻 𝗦𝘂𝗿𝗴𝗲𝗿𝘆
17 years ago, shared insights that are still highly relevant today.
Hemopure is 𝗻𝗼𝘁 𝗮𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗯𝗹𝗼𝗼𝗱, but a 𝗵𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻-𝗯𝗮𝘀𝗲𝗱 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 that reduces the need for blood transfusions, transforming how clinicians manage oxygen delivery.
𝗪𝗵𝗲𝗿𝗲 𝗶𝘁 𝗵𝗲𝗹𝗽𝘀:
- Orthopedic & critical surgeries
- Situations with blood shortages or high infection risk
- Patients with religious restrictions or rare blood conditions
𝗛𝗼𝘄 𝗶𝘁 𝘄𝗼𝗿𝗸𝘀:
- Delivers oxygen immediately, without relying on 2,3-DPG
- Particles 1,000× smaller than red blood cells → reach tissues normal blood cannot
- Enhances oxygenation after heart attacks or in compromised microcirculation
𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲:
- ~200 patients treated
- Can be combined with donor blood
- Adverse events rare and comparable to standard transfusions
- Particularly useful for patients with diabetes or impaired microcirculation
𝗥𝗲𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁: In critical surgeries,Hemopure keeps the heart beating and tissues oxygenated, literally 𝘀𝗮𝘃𝗶𝗻𝗴 𝗹𝗶𝘃𝗲𝘀 .
𝗨𝘀𝗲𝗱 & 𝗲𝗻𝗱𝗼𝗿𝘀𝗲𝗱 𝗯𝘆 𝘁𝗼𝗽 𝗲𝘅𝗽𝗲𝗿𝘁𝘀:
- 𝗗𝗿. Lewis Levien 𝗠𝗗, 𝗣𝗵𝗗 – Pioneering surgeon, South Africa
- 𝗗𝗿. Ivan Schewitz 𝗶𝘁𝘇, 𝗠𝗗 – Cardiothoracic surgery innovator
- 𝗗𝗿. Steve Cohn 𝗠𝗗 Trauma & critical care leader
Product was valuate as
“𝘽𝙚𝙨𝙩 𝘽𝙡𝙤𝙤𝙙 𝙨𝙚𝙧𝙫𝙞𝙘𝙚 𝙞𝙣 𝙏𝙝𝙚 𝙒𝙤𝙧𝙡𝙙 “
𝗡𝗲𝘅𝘁-𝗴𝗲𝗻: 𝗕𝗛𝗢𝗖 Hemopure paved the way for
BHOC – Biological Hemoglobin Oxygen Carrier a new generation product that combines:
- Clinical experience from Hemopure
- AI-driven innovation
- Cutting-edge biotech & scientific knowledge
BHOC represents the 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗼𝘅𝘆𝗴𝗲𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆—smarter, faster, and life-saving.
𝘈𝘶𝘵𝘩𝘰𝘳 𝘰𝘧 𝘝𝘪𝘥𝘦𝘰: 𝘈𝘯𝘥𝘺 𝘉𝘰𝘣𝘳𝘰𝘸”
Stay updated with Hemostasis Today.
-
Nov 14, 2025, 11:58Marilena Vrana: Can Public-only Blood Collection Systems Meet the Growing Patient Need for PDMs?
-
Nov 14, 2025, 11:48Cedric Hermans Shares the 1st Illustrated Review Dedicated to Hemophilia B
-
Nov 14, 2025, 10:28Valance Washington: Proud to Share Our Lab’s Latest Publication in Platelets Journal
-
Nov 14, 2025, 10:18Sripal Bangalore and Ajay Kirtane on TUXEDO-2 Comparison Focusing on Diabetic Patients
-
Nov 14, 2025, 10:11Ashley Lawrenson on Her Coagulation Journey Using Automation With the HemoCell and HemoHub
-
Nov 14, 2025, 10:05Kingsley Wheaton: A Year Ago, Omni Was an Idea – Today, It’s a Movement!
-
Nov 14, 2025, 09:58Rucha Patil Takes The National DHR-ICMR Gold Award for Best Technology
-
Nov 14, 2025, 09:48Caitlin Raymond on ”The Plasma Chasers”
-
Nov 14, 2025, 09:42Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!